Grupo Financiero Galicia S.A. (ADR)  

(Public, NASDAQ:GGAL)   Watch this stock  
Find more results for GGAL
+0.16 (0.65%)
Nov 27 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 24.33 - 25.27
52 week 13.81 - 29.25
Open 25.01
Vol / Avg. 183,347.00/744,353.00
Mkt cap 3.89B
P/E     -
Div/yield 0.09/0.35
EPS     -
Shares 1.02B
Beta 1.78
Inst. own 2%

Key stats and ratios

Q3 (Sep '15) 2014
Net profit margin 17.45% 15.77%
Operating margin 27.41% 24.57%
EBITD margin - 43.77%
Return on average assets 3.85% 3.75%
Return on average equity 37.64% 38.83%
Employees 12,012 -
CDP Score - -


Tte. Gral. Peron 430 25
+54-11-43437528 (Phone)
+54-11-43437528 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Grupo Financiero Galicia S.A. (Grupo Financiero Galicia) is a financial services holding company. Banco de Galicia y Buenos Aires S.A. (Banco Galicia) is the Company's largest subsidiary. Banco Galicia is a bank that provides, directly or through its subsidiaries, a range of financial products and services to large corporations, small and medium sized companies (SMEs), and individuals. Through the operating subsidiaries of Tarjetas Regionales S.A., a holding company wholly owned by the Bank, the Company provides brand credit cards and consumer finance services throughout Argentina. Through Sudamericana Holding S.A. and its subsidiaries (Sudamericana) it provides insurance products in Argentina. It provides financial services through a distribution platform amongst private-sector financial institutions in Argentina.

Officers and directors

Eduardo J. Escasany Chairman of the Board
Bio & Compensation  - Reuters
Pedro A. Richards Chief Executive Officer
Bio & Compensation  - Reuters
Pablo Gutierrez Vice Chairman of the Board
Bio & Compensation  - Reuters
Jose Luis Gentile Chief Administration and Finance Officer
Bio & Compensation  - Reuters
Abel Ayerza Director
Bio & Compensation  - Reuters
Antonio Roberto Garces Director
Bio & Compensation  - Reuters
C. Enrique Martin Director
Bio & Compensation  - Reuters
Federico Mauricio Braun Director
Bio & Compensation  - Reuters
Luis Omar Oddone Director
Bio & Compensation  - Reuters